PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS- Via Portuense, 292- 00149, Rome, Italy. alessandra.sacchi@inmi.it.\', \'National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS- Via Portuense, 292- 00149, Rome, Italy.\', \'Immunotherapy Programme, Champalimaud Centre for the Unknown, Lisbon, Portugal.\', \'I Med Clinic, University of Mainz, Mainz, Germany.\', \'Division of Infection and Immunity, University College London, London, UK.\', \'National Institute of Health Research Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.\', \'Department of Pediatric Hematology and Oncology, Ospedale Pediatrico Bambino Gesù, Istituto di Ricovero e Cura a Carattere Scientifico, Sapienza, University of Rome, Rome, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41419-020-03125-1
?:hasPublicationType
?:journal
  • Cell death & disease
is ?:pmid of
?:pmid
?:pmid
  • 33110074
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all